To see the other types of publications on this topic, follow the link: Antioncogenes.

Dissertations / Theses on the topic 'Antioncogenes'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Antioncogenes.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Campbell, Hamish George, and n/a. "The functions of p53 during an adenovirus infection." University of Otago. Dunedin School of Medicine, 2008. http://adt.otago.ac.nz./public/adt-NZDU20080411.115504.

Full text
Abstract:
p53 is a pivotal tumour suppressor in mammalian cells. It protects the integrity of a number of cellular pathways, preventing the malignant transformation of cells. There is however perhaps nothing more efficient at disrupting cellular pathways than a virus. Viruses infiltrate cells commandeering the normal growth and survival pathways for their narcissistic needs. While the association between viral infections and the induction of p53 has long been recognised, there is controversy surrounding the ultimate role of p53 during a virus infection. The classical model of p53 in an adenovirus infection is that p53 is a formidable obstacle which needs to be overcome. Adenoviruses overcome p53 by degrading the protein and removing its ability to transactivate its target genes. However the degradation is not immediate and there is increasing evidence which would suggest p53 is actually beneficial to an adenovirus infection. In the introductory chapter, I review what is known about p53 and virus infections. What emerges from this review is the sheer number of interactions that occur between viruses and p53, indicating its importance in an infection. Additionally it shows that adenoviruses are not the only virus shown to benefit from the presence of p53. What beneficial role p53 may be fulfilling in an adenovirus infection is unclear. The experiments reported in this thesis investigate the functions of p53 in an adenovirus infection. In Chapter Three, immunoblots on a panel of adenovirus infected cells reveal that p53 levels do not correlate with the level of the classical p53 target proteins. This indicates that p53 is disconnected from its target genes during an infection. Promoter/reporter assays carried out on infected cells show that adenovirus can directly regulate p53 target genes independently of p53. In Chapter Five, I show this regulation is dependent on E1a, with transient transfection of E1a resulting in the marked activation of p53 target promoters. E1a mediated transactivation appears to be reliant on the largest splice variant of E1a (E1a-289R) and the presence of pRB. Electrophoresis mobility shift assays reveal that the transcription factor Sp1 is involved. In Chapter Four, p53 transcription in an adenovirus infection was directly assayed by using an artificial p53 consensus response element. The results show that p53 is unable to activate its consensus response element during an infection. However, I show that p53 is transcriptionally competent in an infection, and is able to transactivate a mutant derivative of the p53 consensus sequence. This shows that p53 is not only transcriptional competent but has a gain-of-function in an infection. This gain-of-function requires E1a, and appears not to be due to a change in the DNA binding affinity of p53. The data in this thesis show that adenoviruses not only appear to inhibit and control the normal transcriptional profile of p53 but appear to modify p53, giving it a new transcriptional profile. This provides a possible mechanism by which p53 could aid an adenovirus infection.
APA, Harvard, Vancouver, ISO, and other styles
2

Evdokiou, Andreas. "Tumour-suppressive activity of the growth arrest-specific gene, GAS1 /." Title page, contents and summary only, 1997. http://web4.library.adelaide.edu.au/theses/09ph/09PHE928.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wong, Lok-yee Michelle. "Epigenetic inactivation of RASSF1 candidate tumor suppressor gene on 3p21.3 locus in esophageal cancer." Click to view the E-thesis via HKUTO, 2003. http://sunzi.lib.hku.hk/hkuto/record/B31971325.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ng, Chi-heng David. "Subcellular localisation of growth suppressor protein deleted in liver cancer 2 (DLC2)." Click to view the E-thesis via HKUTO, 2005. http://sunzi.lib.hku.hk/hkuto/record/B32028313.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Yau, Wing Lung. "Investigation of candidate tumor suppressor genes mapped to chromosome 3p21.3 in nasopharyngeal carcinoma /." View abstract or full-text, 2006. http://library.ust.hk/cgi/db/thesis.pl?BIOL%202006%20YAU.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Leung, Chi Chung. "Study of a candidate tumor suppressor gene on 9q32, deleted in esophageal cancer 1 (DEC1), in esophageal cancer /." View abstract or full-text, 2006. http://library.ust.hk/cgi/db/thesis.pl?BIOL%202006%20LEUNG.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tsang, Hing-wing. "Analysis of fragile site FRA16D and WWOX gene in non-small cell lung cancer /." View the Table of Contents & Abstract, 2005. http://sunzi.lib.hku.hk/hkuto/record/B34829416.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Leung, Ho-yin Thomas. "Identification and characterization of a novel tumor suppressor gene, delected in liver cancer 2, (DLC2)." Click to view the E-thesis via HKUTO, 2005. http://sunzi.lib.hku.hk/hkuto/record/B36445058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zhu, Cailei. "Characterization of tumor suppressing function of PCAF in esophageal squamous cell carcinoma." Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/HKUTO/record/B39557480.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wong, Lai-ting. "Study of the role of the tumor suppressor phosphatase and tensin homolog (PTEN) in hepatocellular carcinoma." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B41290495.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Ko, Chi-fat. "Molecular regulations of deleted in liver cancer (DLC) protein family." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B41896889.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Cheng, Yue. "Identification of putative tumor suppressor gene activities in nasopharyngeal carcinoma /." View Abstract or Full-Text, 2002. http://library.ust.hk/cgi/db/thesis.pl?BIOL%202002%20CHENG.

Full text
Abstract:
Thesis (Ph. D.)--Hong Kong University of Science and Technology, 2002.
Includes bibliographical references (leaves 164-192). Also available in electronic version. Access restricted to campus users.
APA, Harvard, Vancouver, ISO, and other styles
13

Yang, Lichun. "Investigation of tumor suppressive role of chromosome 9 in esophageal squamous cell carcinoma /." View abstract or full-text, 2004. http://library.ust.hk/cgi/db/thesis.pl?BIOL%202004%20YANG.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Guo, Tianhuan. "Identification of tumor suppressor genes in the commonly deleted region of chromosome 6q in NK-cell malignancies." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43785761.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Lui, Lik-hang Eric. "Aberrant methylation of E-cadherin gene (ECAD) in invasive ductal breast carcinoma /." View the Table of Contents & Abstract, 2005. http://sunzi.lib.hku.hk/hkuto/record/B31361912.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Leung, Pui-ling Pauline. "The role of p16 tumor suppressor gene in the diagnosis of thyroid disease /." View the Table of Contents & Abstract, 2006. http://sunzi.lib.hku.hk/hkuto/record/B36433810.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Bender, Aaron. "Involvement of lin-35/Rb in C. elegans reproductive system development." Laramie, Wyo. : University of Wyoming, 2006. http://proquest.umi.com/pqdweb?did=1188872161&sid=2&Fmt=2&clientId=18949&RQT=309&VName=PQD.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

王洛儀 and Lok-yee Michelle Wong. "Epigenetic inactivation of RASSF1 candidate tumor suppressor gene on 3p21.3 locus in esophageal cancer." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2003. http://hub.hku.hk/bib/B31971325.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

祝彩磊 and Cailei Zhu. "Characterization of tumor suppressing function of PCAF in esophageal squamous cell carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B39557480.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Chen, Juan Catherine, and 陈娟. "Tumor suppressor genes associated with deletion in short arm of chromosome 3 in nasopharyngeal carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/210237.

Full text
Abstract:
Nasopharyngeal carcinoma (NPC) is one of the most common malignancies in southern China. Deletion of genomic DNA, which occurs during the complex pathogenesis process for NPC, represents a pivotal mechanism in the inactivation of tumor suppressor genes (TSGs). In many circumstances, loss of TSGs can be detected as diagnostic and prognostic markers in cancer treatment. It is found that the short arm of chromosome 3 (3p) is frequently deleted in NPC, with two most frequently minimally deleted regions at 3p21.1-21.2 and 3p25.2-26.1. Recently, our research group and others have focused on the identification and characterization of novel TSGs in the 3p deleted region. Three new tumor suppressor genes, CACNA2D3, RBMS3 and CHL1 were identified by our group. In this thesis, I found thatRBMS3at3p24was down-regulated in 3/3 NPC cell lines and 13/15 (86.7%) primary NPC tissues, compared with corresponding non-tumor tissues. Functional study demonstrated that RBMS3hadstrong tumor suppressive function in NPC cells, including inhibiting the cell growth rate, colony formation in soft-agar and tumor formation in nude mice. Moreover, the tumor suppressive mechanism of RBMS3was involved with the cell cycle arrest at the G1/S checkpoint.RBMS3 also had a pro-apoptotic role in a mitochondrial-dependent manner. Finally, RBMS3 could inhibit microvessel formation. Located at the important tumor suppressor locus 3p26.1, CHL1encodes a one-pass trans-membrane cell adhesion molecule (CAM). I identified CHL1as a tumor suppressor gene in nasopharyngeal carcinoma through expression profiling and epigenetic characterization. In this study, down-regulation of CHL1 was detected in 3/3of NPC cell lines and 12/15 (80.0%) of NPC tissues. Expression of CHL1could be reversed by pharmacological demethylation with 5-aza, indicating that promoter methylation might play an important role inCHL1down-regulation. Functional study showed that ectopic expression of CHL1 in NPC cells could dramatically inhibit clonogenicity and cell motility, possibly through cell cycle arrest. Further study found that CHL1 was able to induce mesenchymal-epithelial transition (MET), a key event to prevent tumor invasion and metastasis, by up-regulating epithelial markers and down-regulating mesenchymal markers. In addition, CHL1could inactivate RhoA/Rac1/Cdc42 signaling pathway to decrease the formation of stress fiber, lamellipodia and filopodia. In conclusion, these findings demonstrate thatCHL1is an important tumor suppressor gene in NPC. Later, I identified CHL1 could co-localize with integrin-beta1, an adhesion molecular, and expression of CHL1 was positively correlated with integrin-beta1. Moreover, CHL1 could interact with integrin-beta1 by using pull-down assay. Also, the tumor suppressor merlin could interact with CHL1. However, when CHL1 is lost, integrin beta1-AKT pathway would be activated and merlin will be phosphorylated and become inactivated, then it could not function as a tumor suppressor anymore. In this thesis, I summarize my recent work on two TSGs at 3p, RBMS3and CHL1, in the development and progression of NPC. Better understanding of TSGs at 3p will greatly improve our knowledge on pathogenesis of NPC, diagnosis and treatment.
published_or_final_version
Clinical Oncology
Doctoral
Doctor of Philosophy
APA, Harvard, Vancouver, ISO, and other styles
21

Chan, Pui Wai. "Fhit : a novel interacting partner of G[alpha][subscript q] proteins /." View abstract or full-text, 2008. http://library.ust.hk/cgi/db/thesis.pl?BICH%202008%20CHAN.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Wallingford, John Beckett. "Tumor suppressors and oncogenes in the development of Xenopus laevis /." Digital version accessible at:, 1998. http://wwwlib.umi.com/cr/utexas/main.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Kwong, Fung Mei. "Investigation of a known tumor suppressor gene, p161NK4a, in human esophageal squamous cell carcinoma cell lines /." View Abstract or Full-Text, 2003. http://library.ust.hk/cgi/db/thesis.pl?BIOL%202003%20KWONG.

Full text
Abstract:
Thesis (M. Phil.)--Hong Kong University of Science and Technology, 2003.
Includes bibliographical references (leaves 74-87). Also available in electronic version. Access restricted to campus users.
APA, Harvard, Vancouver, ISO, and other styles
24

Francoz, Sarah. "Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo." Doctoral thesis, Universite Libre de Bruxelles, 2006. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/210858.

Full text
Abstract:
The Mdm2 and Mdm4 oncoproteins are key negative regulators of the p53 tumor suppressor. However, their physiological contributions to the regulation of p53 stability and activity remain highly controversial. Here, we combined a p53 knock-in allele, in which p53 is silenced by a transcriptional stop element flanked by loxP sites, with the Mdm2- and Mdm4-null alleles. This approach allows Cre-mediated conditional p53 expression in tissues in vivo and cells in vitro lacking Mdm2, Mdm4, or both. Using this strategy, we show that Mdm2 and Mdm4 are essential in a nonredundant manner for preventing p53 activity in the same cell type (Mouse Embryonic Fibroblasts (MEFs), neuronal progenitor cells and postmitotic neurons) and irrespective of the proliferation/differentiation status of the cells. Although Mdm2 prevents accumulation of the p53 protein, Mdm4 contributes to the overall inhibition of p53 activity independent of Mdm2. We propose a model in which Mdm2 is critical for the regulation of p53 levels and Mdm4 is critical for the fine-tuning of p53 transcriptional activity, both proteins acting synergistically to keep p53 in check. Finally, we show that neither Mdm2 nor Mdm4 regulate cell cycle progression independently of its ability to modulate p53 function.
Doctorat en sciences, Spécialisation biologie moléculaire
info:eu-repo/semantics/nonPublished
APA, Harvard, Vancouver, ISO, and other styles
25

Cheng, Wan-biu. "Genetic analysis on the EPHB2 gene in breast cancer /." View the Table of Contents & Abstract, 2005. http://sunzi.lib.hku.hk/hkuto/record/B31494316.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Fung, King-leung. "Molecular study of the deleted in liver cancer 2 (DLC2)h[electronic resource] : solution structure of the SAM domain and interaction with MCM7 /." Click to view the E-thesis via HKUTO, 2005. http://sunzi.lib.hku.hk/hkuto/record/B36218716.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Tang, Dongjiang. "Functional studies of SEI-1 and eIF5A2 : candidate oncogenes isolated from frequently amplified regions of ovarian carcinomas /." Click to view the E-thesis via HKUTO, 2006. http://sunzi.lib.hku.hk/hkuto/record/B36889775.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Guo, Tianhuan, and 郭天欢. "Identification of tumor suppressor genes in the commonly deleted region of chromosome 6q in NK-cell malignancies." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43785761.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Prowse, Amanda Helen. "Genetic alteration of the von Hippel Lindau tumour suppressor gene in sporadic and familial neoplasia." Thesis, University of Cambridge, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.627240.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Cheung, Kwok Leung. "Investigation of candidate tumor suppressor genes on chromosomes 3 and 14 in nasopharyngeal carcinoma /." View abstract or full-text, 2009. http://library.ust.hk/cgi/db/thesis.pl?BIOL%202009%20CHEUNG.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Li, Tung-ching Kathy. "Hypermethylation of tumor suppressor genes in non-small cell lung cancer." Click to view the E-thesis via HKUTO, 2003. http://sunzi.lib.hku.hk/hkuto/record/B31971180.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Ko, Josephine Mun Yee. "Tumor suppressive role of chromosomes 11, 13, and 14 in esophageal squamous cell carcinoma studied by functional complementation /." View abstract or full-text, 2005. http://library.ust.hk/cgi/db/thesis.pl?BIOL%202005%20KO.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Maciel, Marcos Euzébio. "Análise da expressão dos genes BRCA1 e FHIT em carcinomas mamários." reponame:Repositório Institucional da UFPR, 2011. http://hdl.handle.net/1884/26211.

Full text
Abstract:
Orientadora : Profa. Dra. Enilze Maria de Souza Fonseca Ribeiro
Co-Orientador: Prof. Dr. Iglenir João Cavalli
Tese (doutorado) - Universidade Federal do Paraná, Setor de Ciências Biológicas, Programa de Pós-Graduação em Genética. Defesa: Curitiba, 28/02/2011
Bibliografia: fls.72-87
Resumo: Em todo o mundo mais de um milhão de mulheres são diagnosticadas com câncer de mama por ano, e 410.000 vão a óbito em decorrência desta doença, representando 14% dos óbitos de mulheres por câncer. Análises de perda de heterozigose (LOH) em tumores mamários esporádicos têm indicado perdas alélicas frequentes nos locos 17q21 e 3p14, onde estão localizados os genes BRCA1 e FHIT, respectivamente. A redução nos níveis de expressão destes genes também tem sido descrita, e está associada a parâmetros de pior prognóstico no câncer de mama. Embora algumas interações dos produtos destes genes sejam conhecidas, são necessários mais estudos que avaliem a relação entre essas interações nos níveis genômico e de expressão. Com o objetivo de caracterizar a expressão dos genes BRCA1 e FHIT e sua relação com a presença ou ausência de LOH, parâmetros histopatológicos e de evolução clínica, foram avaliadas 47 pacientes portadoras de tumores mamários esporádicos com perfil de LOH estabelecido. As médias da expressão gênica relativa foram determinadas através de qRT-PCR utilizando o método do Cq comparativo. O gene FHIT apresentou média de expressão (0,0299+0,0377, n = 44) aproximadamente três vezes maior do que a do gene BRCA1 (0,0099+0,0054, n=35) ( t’= 3,428 > tc = 2,027). As médias de expressão dos genes apresentaram correlação significativa (r=0,65; p<0,0001). As comparações entre as médias de expressão de BRCA1 e FHIT e os grupos de presença ou ausência de LOH não apresentaram diferenças estatisticamente significativas. De maneira geral, as comparações entre as médias de expressão dos genes e os parâmetros histopatológicos e de evolução clinica não apresentaram diferenças significativas, exceto para o grupo de presença de linfonodos metastáticos, que apresentou média de expressão do BRCA1 menor em relação ao grupo de ausência (t'=2,33 > tc=2,13). Estes dados sugerem uma relação entre os genes que, conforme descrito na literatura, desempenham uma função importante nos processos de gênese e progressão tumoral. Devido as suas conhecidas atuações na regulação do reparo de danos no DNA e no controle da apoptose, alterações na expressão destes genes têm implicações nos parâmetros de pior prognóstico nos cânceres mamários. A regulação dos promotores através de metilação e/ou da ligação de fatores de transcrição e a possível contaminação das amostras com células não tumorais adjacentes podem explicar a ausência de correspondência entre LOH e a expressão gênica.
Abstract: Worldwide over one million of women are diagnosed with breast cancer each year and 410,000 will die due to this disease. This represents 14% of female deaths from cancer. Analysis of loss of heterozygosity (LOH) in sporadic breast tumors have shown frequent allelic losses at loci 17q21 and 3p14, where the BRCA1 and FHIT genes are located, respectively. Lower levels of protein expression of these genes have also been described, in association with poor prognosis parameters in these tumors. Although some interactions of the products of these genes are known, further studies are necessary to assess the correlation among these interactions at the genomic, mRNA and protein levels. To characterize the mRNA expression of BRCA1 and FHIT and their correlation with the presence or absence of LOH, histopathological parameters and clinical outcome, we evaluated 47 sporadic breast cancer patients with an established LOH profile. The relative gene expression was determined by qRT-PCR using the Cq comparative method. The gene expression levels of both genes were significantly correlated (r=0.65, p<0.0001; FHIT - 0,0299+0,0377, n = 44; BRCA1 - 0,0099+0,0054, n=35). However, the comparisons of their expression with the presence or absence of LOH was not statistically significant. The comparisons of gene expression with the histopathopatological parameters and clinical outcome were also not significantly different, except for the group of patients with lymph node metastasis, which presented lower expression levels of BRCA1 in comparison to the patients from the lymph node negative group (t'=2.33 > tc=2.13). These data suggest a correlation among the genes and support the important role that they play in the processes of genesis and tumor progression. Due to their function in the regulation of DNA damage repair and cell death, changes in their expression directly affect breast cancer prognosis. The regulation of the promoter of the genes by methylation and/or binding of transcription factors, and the possible contamination of samples with adjacent non-tumor cells, may explain the absence of correlation between LOH and gene expression.
APA, Harvard, Vancouver, ISO, and other styles
34

Tam, Chun-wai. "Secreted PDZ domain-containing protein 2 (sPDZD2) a potential autocrine tumor suppressor /." Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/HKUTO/record/B39557376.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Wong, Chun-ming, and 黃俊銘. "Characterization of novel tumor suppressor genes, DLC-1 and DLC-2, in hepatocellular carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2003. http://hub.hku.hk/bib/B27768533.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Ng, Chi-heng David, and 吳志恒. "Subcellular localisation of growth suppressor protein deleted in livercancer 2 (DLC2)." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B32028313.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Leung, Ho-yin Thomas, and 梁浩然. "Identification and characterization of a novel tumor suppressor gene, delected in liver cancer 2, (DLC2)." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B36445058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Wong, Lai-ting, and 王麗婷. "Study of the role of the tumor suppressor phosphatase and tensin homolog (PTEN) in hepatocellular carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B41290495.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Ko, Chi-fat, and 高自發. "Molecular regulations of deleted in liver cancer (DLC) protein family." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B41896889.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Tsang, Hing-wing, and 曾慶榮. "Analysis of fragile site FRA16D and WWOX gene in non-small cell lung cancer." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B45010912.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Lo, Hau-yi Paulisally, and 盧巧兒. "Characterization of two candidate tumor suppressor genes: ADAMTS9 and CRIP2 in esophageal squamous cellcarcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B4589498X.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Wong, Chun-lam, and 黃俊霖. "Identification and functional analysis of candidate tumor suppressor genes in chromosome 9 in esophageal squamous cell carcinoma (ESCC)." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B45204214.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Chan, King-chi, and 陳敬慈. "Identification of candidate tumor suppressive BLU/ZMYND 10-modulated genes in nasopharyngeal carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B4520214X.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Huang, Zhiguang, and 黄之光. "Characterization of the tumor suppressive function of alphaB-crystallin (CRYAB) in nasopharyngeal carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46925740.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Zhu, Cailei, and 祝彩磊. "Identification and characterization of CHL1 in esophageal squamous cell carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B46329559.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Cheung, Wai-ying, and 張慧盈. "Characterization of plant homeodomain finger protein 11 (PHF11), a candidate tumor suppressor, in esophageal squamous cell carcinoma." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B50162834.

Full text
Abstract:
Esophageal squamous cell carcinoma (ESCC) is a common cancer worldwide with a high mortality rate. High occurrence of ESCC is observed in Southeast Asia. Identification and characterization of ESCC important tumor suppressor genes will be highly beneficial to the understanding of the disease and for the early diagnosis and improvement of therapy for the cancer. In our previous microcell-mediated chromosome transfer (MMCT) studies, the transfer of an intact chromosome 13 into the recipient ESCC cell line revealed the tumor suppressive ability and putative tumor suppressive function of chromosome 13 in ESCC. One candidate gene, Plant-Homeodomain Finger Protein 11(PHF11), was identified from the study and selected for further functional studies in this current study. PHF11, located on chromosomal region 13q14, contains two plant homeodomain fingers and is a member of the PHD finger protein family. PHF11was reported to be associated with asthma and atopic diseases, yet no studies of PHF11havebeen reported in cancer to date. This study is the first to report the functional role of PHF11in tumor suppression. In this current study, two isoforms of PHF11, PHF11aand b, were reintroduced into ESCC cell lines by methods of transient tranfection and lentiviral-infection. In vitro studies showed both isoforms have cell proliferation and colony-formation inhibition abilities. In the nude mouse tumorigenicity assay, however, it was revealed that only thePHF11aisoform was tumor suppressive in vivo. No differences in angiogenesis-related factors and apoptosis-related factors were observed in PHF11a-and b-expressing cells. Further studies by Western blotting analysis and flow cytometry analysis showed that PHF11amay play a role in delaying cell cycle progression by the down-regulation of cyclin expression, while the PHF11bmay be functionally inactive, The results of this current study further confirm the tumor suppressive role of PHF11ain ESCC, whereas the PHF11b isoform was unable to suppress tumor formation in vivo. Further study of the PHF11 isoforms to identify their differential functions and interacting partners will provide a better understanding of the mechanism by which PHF11a suppressestumor growth.
published_or_final_version
Clinical Oncology
Master
Master of Philosophy
APA, Harvard, Vancouver, ISO, and other styles
47

Toh, Pei Chern Pearl. "Investigating the link between cancer-related genes and autophagy." Thesis, University of Cambridge, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.648643.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Pang, Bo. "Antiproliferative actions of melatonin and secreted PDZ domain-containing protein 2 (sPDZD2) on tumor cells." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43224064.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Ma, Ka-li Marcella. "Epigenetic regulation of gene expression of cystatin 6, CST6, in hepatocellular carcinoma /." View the Table of Contents & Abstract, 2005. http://sunzi.lib.hku.hk/hkuto/record/B31683964.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Kalita, Ann Marie. "Comparison of the activities of two allelic variants of the human wildtype p53 protein." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp04/mq29729.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography